Sorry, you need to enable JavaScript to visit this website.

Find links to the resources that help our business partner relationships run more smoothly. Learn how to set up your portal accounts, read our policies, and connect with the appropriate Business-to-Business departments.
 

Press Releases

Science & Innovation

Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure

Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.

Trusted Voices

You’ve Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round

Aamir Malik is Executive Vice President, Chief U.S. Commercial Officer, Pfizer Inc. Today, he writes about the importance of taking control of your health as you age.

Science & Innovation

Developing a Path Forward in Cancer Cachexia

Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.

Submit Your Opportunities

Have an idea? Send us your opportunity for consideration.

Submit Your Opportunity Details